Reactive oxygen species (ROS) have been closely associated with both apoptotic and non-apoptotic/necrotic cell death. Our previous study has illustrated that c-Jun-N-terminal kinase 1 (JNK1) is the main executor in hydrogen peroxide (H 2 O 2 )-induced nonapoptotic cell death. The main objective of this study is to further elucidate the molecular mechanisms downstream of JNK1 in H 2 O 2 -induced cell death. In this study, poly(ADP-ribose) polymerase-1 (PARP-1), a key DNA repair protein, was readily activated by H 2 O 2 and inhibition of PARP-1 activation by either a pharmacological or genetic approach offered significant protection against H 2 O 2 -induced cell death. More importantly, H 2 O 2 -mediated PARP-1 activation is subject to regulation by JNK1. Suppression of JNK1 activation by a chemical inhibitor or genetic deletion markedly suppressed the late-phase PARP-1 activation induced by H 2 O 2 , suggesting that JNK1 contributes to the sustained activation of PARP-1. Such findings were supported by the temporal pattern of nuclear translocation of activated JNK and a direct protein-protein interaction between JNK1 and PARP-1 in H 2 O 2 -treated cells. Finally, in vitro kinase assay suggests that PARP-1 may serve as the direct phosphorylation target for JNK1. Taken together, data from our study reveal a novel underlying mechanism in H 2 O 2 -induced nonapoptotic cell death: JNK1 promotes a sustained PARP-1 activation via nuclear translocation, protein-protein interaction and PARP-1 phosphorylation.
Reactive oxygen species (ROS) refers to a group of oxygencentered free radicals such as superoxide anion, hydroxyl radicals and hydrogen peroxide (H 2 O 2 ). 1 The production of these free radicals, which can be as high as millimolar quantities in the production sites, has been suggested to be involved in many physiological and pathological conditions. 2 It is known that the disturbed cell redox status owing to enhanced level of ROS and/or impaired antioxidant defense mechanisms induces a cellular oxidative stress, leading to various biological consequences, including apoptotic or necrotic cell death. 3, 4 The involvement of ROS or oxidative stress in cell death is two-fold. First, ROS act as cell death initiators through their direct damaging effect on various macromolecules including protein, DNA and lipid. 5 Depending on the concentration or the cell type, intracellular generated ROS or exogenously applied ROS can cause either apoptosis or necrosis. 6 Second, ROS function as intermediate signaling molecules in the cell death signaling pathways. One example is the role of ROS in tumor necrosis factor (TNF)-mediated both apoptotic and necrotic cell death. 7, 8 Poly(ADP-ribose) polymerase 1 (PARP-1) is the founding member of the PARP family, a group of nuclear enzymes functioning as a critical post-translational regulatory mechanism in the process of DNA damage repair via PARP-1-mediated poly(ADP-ribosyl)ation. 9 Despite its beneficial effect in DNA repair, PARP-1 activation has been implicated in the cell death process. In the case of severe DNA damage, massive PARP-1 activation would quickly deplete cellular b-nicotinamide adenine dinucleotide (NAD þ ), leading to the failure in ATP production and eventually necrotic cell death. 10, 11 Recently, PARP-1 has also been demonstrated to mediate caspase-independent cell death via apoptosisinducing factor (AIF): the PARP-1 overactivation prompts mitochondrial dysfunction and the translocation of AIF from mitochondria to nuclei in cells treated with DNA-damaging agents. 12 c-Jun N-terminal protein kinase (JNK) is an important member of the mitogen-activated protein (MAP) kinase family that plays critical physiological and pathological roles in cells. 13 It has been well established that a variety of extracellular stimuli such as oxidative stress, UV and cytokines activate JNK via a MAP kinase cascade consisting of MAP kinase kinases (MAPKK) and MAP kinase kinase kinases (MAPKKK). The MAPKKK responsible for JNK activation are mainly MEKK1 and ASK1, which phosphorylate and activate two MAPKK, JNKK1/MKK4/SEK1 and JNKK2/ MKK7. 13 Several lines of evidence suggests that JNK is an important mediator in oxidative stress-induced apoptotic cell death, and the proapoptotic function of JNK has been demonstrated in various cell types stimulated with different forms of ROS. 14, 15 On the other hand, the regulatory role of JNK in ROS-induced nonapoptotic cell death was less studied. One of our recent reports demonstrated that JNK plays a critical role in H 2 O 2 -induced caspase-independent nonapoptotic cell death in mouse embryonic fibroblasts (MEF) downstream of tumor necrosis factor receptor (TNFR)-associated factor 2 (TRAF2 and receptor-interacting protein (RIP). 16 However, the signaling mechanism downstream of JNK activation in ROS-induced nonapoptotic cell death has not been fully elucidated. In this study, we demonstrate a novel regulatory role of JNK1 in H 2 O 2 -induced PARP-1 activation and subsequent nonapoptotic cell death. By nuclear translocation, direct protein-protein interaction and phosphorylation, JNK1 facilitates a sustained PARP-1 activation, leading to a severe depletion of cellular ATP, which consequently results in a nonapoptotic cell death.
Results
H 2 O 2 induces a caspase-independent nonapoptotic cell death in wild-type MEF cells. The form of cell death induced by H 2 O 2 varies depending on the concentration as well as cell type. 6 In this study, we first observed a dosedependent increase in cell death in wild-type (wt) MEF treated with a range of H 2 O 2 (up to 1000 mM) and timedependent increase in cell death induced by H 2 O 2 ( Figure 1a) . Notably, the morphological features of cells treated with H 2 O 2 were markedly different from those treated with TNFa. When typical apoptotic alterations such as cell blebbing and chromatin condensation were clearly observed in TNFa-treated cells, no similar changes were found in those cells treated with H 2 O 2 ( Figure 1b) . Instead, many cells lost the membrane integrity (demonstrated by red nucleus stained with ethidium bromide (EB) at the early stage of H 2 O 2 treatment, suggesting that those cells most probably underwent necrotic cell death. As caspase-3 is the principal effector caspase responsible for most of the apoptotic morphological changes, we further tested the involvement of caspase-3 activation in H 2 O 2 -induced cell death. No caspase-3 cleavage was detected in MEF cells treated with H 2 O 2 , whereas a complete cleavage was observed in cells treated with TNFa (Figure 1c) . Consistently, two general caspase inhibitors (Z-VAD and Boc-D) failed to inhibit H 2 O 2 -induced cell death examined by a general cytotoxicity parameter, lactate dehydrogenase (LDH) leakage (Figure 1d ). The effectiveness of those caspase inhibitors were confirmed by their ability to block TNFa-induced apoptosis in HeLa cells (data not shown). Data from this part of our study collectively demonstrate that H 2 O 2 -induced cell death is likely to be nonapoptotic/necrotic and independent of caspase-3 activation.
H 2 O 2 -induced nonapoptotic cell death is dependent on PARP activation. PARP-1 is one of the main defense machinery against DNA damage including oxidative stressinduced DNA damage. 11, 17, 18 Recently, a number of studies have suggested the involvement of PARP-1 activation in caspase-independent cell death induced by DNA damage agents or oxidation agents. 12, 19 In this study, we first examined H 2 O 2 -induced PARP-1 activation in wt MEF. As shown in Figure 2a , a strong formation of poly (ADP-ribose) (PAR) polymer, a direct result of PARP-1 activation, was observed as early as 15 min after H 2 O 2 exposure, whereas no PAR formation was detected in PARP-1 knockout MEF (PARP-1À/À). Moreover, the PARP-1À/À cells appeared to be largely resistant to H 2 O 2 -induced cell death (Figure 2b) . Consistently, pretreatment with a specific PAPR inhibitor, 3AB, significantly inhibited formation of PAR polymer as well as the cellular ATP depletion (Figure 2c JNK regulates PARP activation in H 2 O 2 -induced cell death. JNK is one of the main stress-responsive kinases and has been implicated in oxidative stress-induced apoptosis. 21 In our previous study, we have shown that JNK, especially the JNK1 activation, has a critical role in promoting H 2 O 2 -induced nonapoptotic cell death. 16 As both PARP-1 and JNK1 play an indispensable role in H 2 O 2 -induced cell death, here we try to further examine the possible functional inter-relationship between JNK and PAPR activation in H 2 O 2 -induced cell death. As shown in Figure 3a , significant JNK activation started 15-30 min after H 2 O 2 exposure and maintained at the peak level throughout the period of treatment (up to 2 h), as detected by kinase assay as well as by Western blot (WB) for phosphor-JNK. When pretreated, the wt MEF cells with either a JNK inhibitor (SP600125) or a PARP inhibitor (3AB), SP600125 could effectively inhibit H 2 O 2 -induced JNK activation, whereas PARP inhibitor 3AB has no effect on H 2 O 2 -induced JNK activation (Figure 3b ). Moreover, there was no discernible decrease in JNK activation in PARP-1À/À cells in comparison with wt MEF, suggesting that PARP-1 may not be important for H 2 O 2 -induced JNK activation (Figure 3c ). In contrast, both 3AB and SP600125 significantly suppressed PARP-1 activation (Figure 3d ). These findings thus suggest that JNK activation is likely to act as an important regulator upstream of PARP activation in H 2 O 2 -treated cells.
JNK1 plays a positive regulatory role in promoting a sustained PARP activation. It is generally believed that the PAPR activation is a fast responsive process, which can be observed within minutes of exposure to DNA-damaging agents. 9 Under H 2 O 2 treatment, there is a rapid PARP activation, reaching the peak level at 15 min (Figures 2a and  4) . However, JNK activation appeared to be slower and only Cell morphological changes detected byAO/ EB staining. wt MEF cells were treated with either H 2 O 2 (500 mM) or TNFa (25 ng/ml þ CHX 10 mg/ml) for 12 h followed by AO/EB staining (mixture of 100 mg/ml each of AO and EB) for 10 min. Then, the cells were examined and photographed using a fluorescence microscope. (c) Caspase-3 cleavage detected by WB. wt MEF cells were treated with H 2 O 2 (500 mM Â 12 h) or TNFa (25 ng/Ml) plus CHX (10 mg/ml) for 12 h. (d) General caspase inhibitors (z-VAD and Boc-D) were unable to block H 2 O 2 -induced cell death. Cells were pretreated with both inhibitors (50 mM) for 30 min before H 2 O 2 exposure (500 mM Â 24 h). In (a) and (d), the percentage of cell death was determined by LDH leakage and data were presented as means 7 S.D. of three independent experiments (**Po0.01, t-test). In (b) and (c), representative results were presented from three independent experiments SP600125 pretreatments significantly shortened the duration of PARP activation, without significant effect on the early time point (15 min) (Figure 4a ). It thus seems that there are two possible phases of PARP activation in response to H 2 O 2 , and JNK1 may positively regulate PARP activation in the second and extended phase. This notion was further supported by using JNK1 knockout MEF cells (JNK1À/À). First, H 2 O 2 -activated PARP-1 was largely diminished in JNK1À/À cells, although it was still visible at the early stage of H 2 O 2 treatment (15 min) ( Figure 4b ). It is also noted that the phosphorylation of total JNK could still be detected in the JNK1À/À cells owing to the presence of JNK2, which suggests that activation of JNK1, but not JNK2, contributes to the sustained phase of PARP activation. In order to verify the role of JNK1 in H 2 O 2 -induced PARP activation, we examined the effect of JNK1 protein reconstitution on H 2 O 2 -induced PARP-1 activation, using JNK1À/À cells transfected with a JNK1 expression vector (HA-JNK1). As shown in Figure 4c , the reconstitution of JNK1 induced a more extensive and sustained PARP activation upon H 2 O 2 exposure, well corresponding to the sustained JNK activation observed in those cells (Figure 4c) . Therefore, the above data collectively indicate that JNK1 may play a positive role in promoting sustained PARP activation.
H 2 O 2 induces JNK nuclear translocation upon its activation. JNK nuclear translocation is known to be one of its signal transduction mechanisms. 22 To further understand the possible effects of JNK1 on PARP activation, here we examined the nuclear translocation of phospho-JNK upon H 2 O 2 treatment in wt MEF cells, using immunofluoresence staining. As shown in Figure 5 , there was a significant increase in the phosphor-JNK staining 15 PARP is a nuclei-localized protein, 23 the evident nuclear translocation of activated JNK provides a prerequisite for the functional interaction between JNK and PARP.
JNK1 directly associates and phosphorylates PAPR-1. It has been well established that components of nuclear transcription factor AP-1 are the most important nuclear substrates for JNK in stress response. 24 Currently, there is no direct evidence demonstrating that JNK targets other nuclear proteins and regulates their functions. Here, we attempted to elucidate the direct function impact of JNK on PARP-1. We first examined the protein-protein interaction between JNK and PARP by endogenous co-immunoprecipitation (co-Ip) experiments. As shown in Figure 6a , H 2 O 2 treatment clearly promoted the protein-protein interaction between JNK1 and PARP-1, evidenced by the increased amount of PARP-1 pulled down by JNK1 (top panel). Importantly, the temporal pattern of such interaction is found to be generally consistent with JNK1 activation (Figure 6a , second panel) and nuclear translocation ( Figure 5) . Moreover, the interaction between JNK1 and PARP-1 is believed to be specific as proliferating-cell nuclear antigen (PCNA), a DNA replication-related protein abundantly localized in nuclei, was not found in the complex (Figure 6a, bottom panel) . All these observations clearly suggest that H 2 O 2 is capable of inducing a direct association between JNK1 and PARP-1.
After establishing the protein-protein interaction between JNK1 and PARP-1, we next examined the possibility that PARP-1 serves as the substrate for JNK1. In this study, we performed the in vitro kinase assay by using human recombinant PARP-1 protein as the substrate. 25 As shown in Figure 6b , phosphorylation of PARP-1 protein could be observed depending on time after incubation with immunoprecipitated JNK1 protein from H 2 O 2 -treated cells. The phosphorylation of GST-c-Jun, the known substrate of JNK, was also detected as a positive control. More importantly, a time-dependent change of 32 P-labeled PARP-1 was well correlated to the temporal pattern of JNK1 activation, and the phosphorylation of PARP-1 was greatly suppressed depending on time by a JNK-inhibitor SP600125 (Figure 6b) . To exclude the possibility that phosphorylation of PARP-1 observed in the above system was mediated by other proteins coexisting in the immunoprecipitation complex, we here used active recombinant JNK1 protein in the kinase assay. As show in Figure 6c , the presence of activated JNK1 produced both JNK1 auto-phosphorylation as well as a strong phosphorylation of GST-c-Jun. More importantly, consistent with the data in Figure 6b , the recombinant JNK1 protein also clearly phosphorylated PARP-1 protein. Hence, data from this part of our study provide convincing evidence that PARP-1 serves as a direct molecular target for JNK1 in cells under oxidative stress.
Discussion
The involvement of ROS or oxidative stress in apoptosis has been extensively studied, either as direct inducers or as intermediate regulators. 6, 26 In contrast, relatively little is known about the signaling pathways in ROS or oxidative stress-mediated nonapoptotic cell death. An earlier report from our laboratory demonstrated a unique signaling pathway in H 2 O 2 -induced caspase-independent non-apoptotic cell death: H 2 O 2 prompts protein-protein interaction between RIP and TRAF2 that subsequently mediates JNK activation. 16 In this study, we attempted to elucidate the molecular mechanisms downstream of JNK in H 2 O 2 -mediated nonapoptotic cell death. Here, by using both pharmacological and genetic approaches, we identified PARP-1 as an important downstream target of JNK in H 2 O 2 -induced nonapoptotic cell death. By nuclear translocation, direct interaction and phosphorylation of PAPR-1, activated JNK1 acts as a positive regulator to render a sustained PARP-1 activation and subsequent cell death. Hence, results from this study reveal a novel regulatory mechanism by JNK1 in controlling the nonapoptotic cell death processes under oxidative stress. JNK is one of the main groups of MAPK that are readily activated in response to various environmental stresses and plays a critical role in the processes deciding the fate of the cells. 13 Although most of the current evidence points to the proapoptotic function of JNK in apoptosis induced by ROS or oxidative stress via sustained JNK activation, 27 there are reports showing the importance of ROS-mediated JNK activation in non-apoptotic or necrotic cell death. For instance, ROS-mediated sustained JNK activation plays a critical role in TNFa-induced necrotic cell death. 28, 29 In our previous study, we have demonstrated that JNK activation is closely involved in nonapoptotic cell death elicited by exogenously applied H 2 O 2 in MEF cells. 16 However, the molecular events downstream of JNK in nonapoptotic or necrotic cell death are still elusive.
PARP-1 is a highly abundant nuclear protein and plays a critical role in DNA repair, DNA stability and gene transcription. 30 Several lines of evidence have suggested that PARP-1 is the key executor involved in necrotic cell death induced by ROS or DNA-damaging agents: excessive activation of PARP-1 leads to depletion of NAD þ and collapse of ATP production, resulting in necrotic cell death as a consequence of energy loss. 18 Recent studies have also highlighted some other mechanisms downstream of PARP-1 activation in cell death, including transcriptional regulation of cell death related genes, such as nuclear factor-ê B and p53 31 and induction of mitochondrial dysfunction and release of AIF to mediate caspase-independent cell death. 12 In this study, we first confirmed the critical role of PARP-1 in 25 In this study, we provide evidence that JNK may act as an upstream regulator of PARP activation in H 2 O 2 -induced cell death, based on observations using a JNK inhibitor and JNK1À/À MEF cells (Figures 3 and 4) . More importantly, JNK1 is believed to act as a positive-modulator to promote a sustained PARP-1 activation, based on observations that JNK1 inhibition did not affect the initial PARP-1 activation, but markedly suppress PARP-1 activation in the extended period. Such a notion is further supported by the temporal pattern of JNK1 nuclear translocation upon H 2 O 2 exposure ( Figure 5 ). Another interesting finding is that in JNK1À/À cells, there is still considerable level of total JNK activation upon H 2 O 2 treatment, due to the activation of JNK2. It is thus believed that JNK1, but not JNK2, play a dominant role in regulating PARP-1 activity in response to H 2 O 2 exposure. Such a finding is in line with our previous observation that only JNK1À/À, but not JNK2À/À MEF, is resistant to H 2 O 2 -induced cell death. 16 The next important question needs to be answered is how PARP-1 activity is regulated by JNK1. Currently, several regulatory mechanisms of PARP-1 activity have been proposed: first, PARP auto-poly(ADP-ribosyl)ation as a negative model of modulation of PARP-1 activity and 32 second, phosphorylation of PARP-1 by a number of protein kinases, such as protein kinase C (PKC), DNA-dependent protein kinase (DNA-PK), AMP-activated protein kinase (AMPK), and ERK1/2. 25, 33, 34 In this study, we, for the first time, provide evidence showing that PARP-1 may serve as a substrate for JNK1. First, PARP-1 interacts with JNK1 in Figure 5 Nuclear translocation of activated JNK. wt MEF cells were treated with H 2 O 2 (500 mM) for up to 60 min. At the end of the treatment, cells were fixed and the phospho-JNK was examined using immunostaining with counterstaining of nuclei by DAPI. All the images were captured by Olympus FLOVIEW V500 confocal microscope. Data were the representative images from three independent experiments H 2 O 2 -treated cells detected by the endogenous co-immunoprecipitation, with a temporal pattern largely consistent with JNK activation and nuclear translocation. Second, either activated JNK1 immunoprecipitated from H 2 O 2 -treated cells or the active recombinant JNK1 was able to directly phosphorylate recombinant PARP-1 protein in the in vitro kinase assay. At this stage, it is still controversial whether PARP-1 protein phosphorylation promotes or suppresses its activity. For example, PKC or DNA-PK has been shown to phosphorylates and inhibits PAPR-1 activity by disrupting its DNA-binding capability. 33, 35 In contrast, PARP-1 phosphorylation mediated by AMPK or ERK1/2 was found to promote the catalytic activity of PARP-1. 25, 36 The contradictory role of phosphorylation suggests that the impact of protein phosphorylation status on the bioactivity of PARP-1 is context-dependent. Data from this study tend to suggest that JNK1 positively regulates PARP-1 activity by means of phosphorylation, similar to the function of ERK1/2 on PARP-1 in MNNG-treated cells. 25 Nevertheless, the exact nature of such effect remains to be further investigated, including the identification of the phosphorylation sites and the physiological relevance of phosphorylation of PARP-1 by JNK1.
Interestingly, our finding that JNK acts as an upstream regulator of PARP-1 is complimentary to some recent reports in which PARP-1 is found to contribute to JNK activation. For instance, Xu et al. demonstrated that, in cells treated with a DNA damage agent MNNG, PARP-1 contributes to JNK activation and cell death via RIP and TRAF2. 19 Similarly, PARP-1 has been found to modulate AP-1 transcriptional activity through JNK activation. 37 It is thus possible that there is a positive feedback loop between JNK and PARP-1 that affects each other's function depending on the nature of stimuli and cell type (Figure 6d ).
Taken together, results from our study reveal a novel signaling pathway underlying ROS or oxidative stressmediated nonapoptotic/necrotic cell death: H 2 O 2 -activated JNK1 acts a positive regulator in promoting a sustained PARP-1 activation via phosphorylation. Understanding such a mechanism helps to appreciate the molecular events controlling ROS-mediated nonapoptotic cell death downstream of JNK. The specific JNK inhibitor SP600125 and general caspase inhibitors Z-VAD and Boc-D were from Calbiochem (San Diego, CA, USA). Anti-phospho-JNK and anticaspase-3 antibodies were purchased from Cell Signaling (Danvers, MA, USA). Anti-PAPR-1 and anti-JNK1 antibody for immunoprecipitation and anti-PCNA for WB were from Santa Cruz (Santa Cruz, CA, USA). Anti-PAR, anti-JNK1 and anti-PARP antibody were from BD Pharmingen (Los Angeles, CA, USA). Mouse recombinant TNFa was from R&D (Minneapolis, MN, USA). The general cytotoxicity detection ( LDH) kit was from Roche (Indianpolis, IN, USA). Active recombinant JNK1 protein was from Upstate (Lake Placid, NY, USA).
Cell culture and detection of cell death. Immortalized wt and JNK1 knockout (JNK1À/À) MEF were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, glutamine (2 mM), penicillin (100 U/ml) and streptomycin (100 mg/ml). PARP-1 knockout (PARP-1À/À) and its corresponding wt MEF were obtained from Dr. ZQ Wang 38 and cultured similarly as above. Cells were subcultured 12 h before treatment and reached about 70% cell confluence at the time of treatment. Upon various designated treatments, cell death in MEF was examined using the following methods: (i) AO/EB staining to distinguish apoptotic and necrotic cell death in morphology 39 and (ii) LDH leakage quantified using a cytotoxicity detection kit (Roche) for measuring the changes of plasma membrane permeability. ATP measurement. Intracellular ATP level was determined using a bioluminescent somatic cell assay kit (Sigma) based on the procedures recommended by the manufacturer. Briefly, after designated treatments, cells culture dishes were immediately put on ice, and cells were collected by ice-cold cell dissociation solution (Sigma) and then resuspended in ice cold phosphate buffer saline (PBS) (pH ¼ 7.8). About 100 000 cells were incubated with freshly prepared ATP assay mix and ATP releasing reagent and then subjected to bioluminescent detection. The ATP level was presented as percentage to the untreated control group.
Transient transfection. PARP-1 expression vector (pPARP31) was kindly provided by Professor Alexander Bürkle. 20 The transient transfection of PARP-1 expression vector into PARP-1À/À cells were performed using electroporationbased method. The vector (4 mg DNA) was diluted with MEF2 nucleofector reagent (Amaxa GmbH, Koeln, Germany) and mixed with 1 Â 10 6 cells. After incubation for 5 min, cells were subjected to electroporation using Program A23. The transfection efficiency was examined by transfection MEF cells with pMaxFPt-Green vector (Amaxa) in parallel. After 24 h, more than 80% cells were confirmed to be successfully transfected. The transient transfection of HA-JNK1 expression vector into JNK1À/À cells was also carried out as described above.
JNK kinase assay and detection of phosphorylation of recombinant PARP-1. JNK kinase assay was performed as described previously. 16 Briefly, at the end of designated experiments, cell lysate was collected using M2 buffer (20 mM Tris at pH 7, 0.5% NP-40, 250 mM NaCl, 3 mM EDTA, 3 mM EGTA, 2 mM DTT, 0.5 mM PMSF, 20 mM -glycerol phosphate, 1 mM sodium vanadate, 1 mg/ml leupeptin). JNK1 protein was immunoprecipitated from 500 mg of total cell lysate with 1 mg anti-JNK1 antibody (Santa Cruz) and harvested with protein A-sepharose beads (Roche). The immunoprecipitates were washed extensively with M2 buffer for three times and incubated with GST-c-Jun in complete kinase assay buffer (20 mM HEPES pH 7.5, 20 mM b-glycerol phosphate, 10 mM MgCl 2 , 1 mM DTT, 10 mM PNPP, 50 mM sodium vanadate, 20 mM ATP) by the addition of 32 P-g-ATP. After incubation at 301C for 30 min, the reaction was stopped by the addition of SDS sample buffer. The samples were then separated on a SDS-PAGE and visualized by autoradiography.
In vitro detection of phosphorylation of recombinant PARP-1 was performed generally similar to JNK kinase assay. For the assay using immunoprecipitated JNK1, the cell lysate was collected using M2 buffer at the end of the designated treatment. After balanced by total protein content, the JNK1 protein was immunoprecipitated with anti-JNK1 antibody (Santa Cruz) and protein A-sepharose beads. Then, the assay was performed for 30 min at 301C with 32 P-g-ATP and recombinant PAPR-1 protein (5 U) as a substrate. GST-c-Jun was also included in parallel as a positive control for JNK-1 activity. For the assay using active recombinant JNK1 protein, 2 mg of activated recombinant JNK1 protein was incubated with recombinant PAPR-1 protein (5 U) directly at 301C for 30 min with 32 P-g-ATP in complete kinase buffer and then subjected to SDS-PAGE and autoradiography.
Immunofluorescence and confocal microscopy. Briefly, the wt MEF cells were plated on the eight well chamber slides (Nunc) and cultured overnight before treatments. At the end of designated treatments, cells were washed with PBS once and fixed in 3.75% paraformaldehyde for 1 h at room temperature and permeabilized with 0.1% Triton-X in PBS for 5 min and blocked in blocking solution (2% BSA, 0.2% tween-20 in PBS) for another 1 h. Cells were further incubated with anti-phospho-JNK antibody (Cell signaling) overnight at 41C with gentle shaking. After washing with washing buffer (PBS with 0.2% Tween-20) for three times, cells were further incubated with fluorescein isothiocyanate-labeled secondary antibody (1:100) for 1 h at room temperature. Then the slides were extensively washed with washing buffer and amounted with ProLong s Gold Anti-Fade mounting solution with DAPI (Invitrogen). The immunofluorescence was visualized by Olympus FLOVIEW V500 confocal microscope.
Co-IP and Western blot. For the Co-IP experiments, cell lysate was prepared as described above using M2 buffer. The cell lysate was mixed and incubated with anti-JNK1 antibody (Santa Cruz) and protein A-sepharose beads (Roche) and incubated at 41C in a head-to-head rotator for at least 4 h. After extensive washing with the M2 cell lysis buffer for four times, protein A beads were boiled in SDSsample buffer to release the protein. Then, the bound proteins were resolved on SDS-PAGE and probed with respective antibodies in WB.
For WB, after various designated treatments, cells were collected and washed with PBS before they were lysed in M2 buffer. The cell lysate was collected after centrifugation (12 000 r.p.m. Â 15 min) and 30 mg of protein was then fractionated on SDS-PAGE and blotted onto polyvinylidene-fluoride membrane (Bio-Rad). After blocking in 5% milk in PBST (PBS with 0.05% Tween 20) for 1 h, the membrane was probed with various first antibodies overnight at 41C, followed by incubation with respective second antibodies for 1 h. The membrane was washed in PBST and developed with enhanced chemiluminescence following the manufacturer's instructions (Pierce).
